COMBINED USE OF AB-132 (METUREDEPA, TURLOC) AND X-IRRADIATION IN THE MANAGEMENT OF ADVANCED BRONCHOGENIC CARCINOMA.
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D001388:Aziridines; D035843:Biomedical Research; D002219:Carbamates; D002283:Carcinoma, Bronchogenic; D007970:Leukopenia; D009369:Neoplasms / Q000532:radiotherapy*; D010336:Pathology; D013921:Thrombocytopenia; D014116:Toxicology
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D001388:Aziridines; D002219:Carbamates; C024217:meturedepa
ALKYLATING AGENTS; ANTINEOPLASTIC AGENTS; CARBAMATES; CARCINOMA, BRONCHOGENIC; CLINICAL RESEARCH; LEUKOPENIA; NEOPLASM RADIOTHERAPY; PATHOLOGY; THROMBOPENIA; TOXICOLOGIC REPORT